MedTrace Logo

Effects of Continuous Venous Dialysis and Hemodialysis on Fluid Dynamics by Bioreactance Method

NCT03905122 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2020-10-08

No results posted yet for this study

Summary

Dialysis methods applied at the bedside and dialysis methods applied in hemodialysis unit are widely applied in patients with renal insufficiency. Especially hemodynamically affected patients are less affected by hemodynamics as a result of using dialysis methods. It is a completely non-invasive method by bioreactance method and it can be done to measure the intra-body fluid status with the help of the glued probes. The aim of this study is to investigate the effects of continuous venous dialysis and hemodialysis on the fluid dynamics applied at the bedside with bioreactance method. In this way, the patient can develop more comfortable hemodynamic changes. Patients in the Surgery, Reanimation and Postoperative Intensive Care Unit with more than 24 hours of hospitalization and bedside dialysis or hemodialysis will be included in the study. Before the dialysis, body fluid measurements will be made with bioreactance, and after dialysis in patients receiving hemodialysis, and in dialysis patients 6, 12, 24 and 36 hours.

Conditions

  • Renal Dialysis

Interventions

DEVICE

bioreactans tool

It is a completely non-invasive method by bioreactance method and it can be done to measure the intra-body fluid status with the help of the probes.

Sponsors & Collaborators

  • Trakya University

    lead OTHER

Principal Investigators

  • Ahmet Senol Uyar, Specialist · Trakya University, Edirne

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-15
Primary Completion
2020-06-15
Completion
2020-06-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03905122 on ClinicalTrials.gov